Immunology of allergic contact dermatitis

Acta Dermatovenerologica Croatica

Volumn 19, Issue 1, 2011, Pages 51-68

  Tonc̈ić, Ruz̈ica Jurakić ^a   Lipozenc̈ić, Jasna ^a   Martinac, Ivana ^a   Gregurić, Sanja ^b  

^a KBC Zagreb   (Croatia)

^b Private dermatologic office Sanja Greguri   (Croatia)

Author keywords

CD8+ cells; Contact allergen; Contact allergic dermatitis; Hapten; Immunology

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HAPTEN; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; PROSTAGLANDIN; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; VASCULAR CELL ADHESION MOLECULE 1;

ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTACT ALLERGY; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; EFFECTOR CELL; HUMAN; IMMUNOLOGY; IMMUNOREGULATION; INNATE IMMUNITY; KERATINOCYTE; LANGERHANS CELL; MAST CELL; MEMORY CELL; NATURAL KILLER CELL; NATURAL KILLER T CELL; REGULATORY T LYMPHOCYTE; SKIN ALLERGY; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; THROMBOCYTE;

ADAPTIVE IMMUNITY; DERMATITIS, ALLERGIC CONTACT; FEMALE; HUMANS; IMMUNITY, INNATE; IMMUNIZATION; LANGERHANS CELLS; MALE; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES;

EID: 79955383597     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (133)

1. Vocanson M, Hennino A, Rozières A, Poyet G, Nicolas JF. Effector and regulatory mechanisms in allergic contact dermatitis. Allergy 2009;64:1699-1714.
2. Gober MD, Gaspari AA. Allergic contact dermatitis. Curr Dir Autoimmun 2008;10:1-26.
3. Cavani A. Immune regulatory mechanisms in allergic contact dermatitis and contact sensibilization. Chem Immunol Allergy 2008;94:93-100.
4. Girolomoni G, Gisondi P, Ottaviani C, Cavani A. Immunoregulation of allergic contact dermatitis. J Dermatol 2004;31:264-1270.
5. Larsen JM, Geisler C, Nielsen MW, Boding L, Von Essen M, Hansen AK, et al. Cellular dynamics in the draining lymph nodes during sensitization and elicitation phases of contact hypersensitivity. Contact Dermatitis 2007;57:300-38.
6. Krasteva M, Kehren J, Ducluzeau MT, Sayag M, Cacciapuoti M, Akiba H, et al. Contact dermatitis I. Pathophysiology of contact sensitivity. Eur J Dermatol 1999;9:65-77.
7. Saint-Mezard P, Krasteva M, Chavagnac C, Bosset S, Akiba H, Kehren J, et al. Afferent and efferent phases of allergic contact dermatitis (ACD) can be induced after a single skin contact with haptens: evidence using a mouse model of primary ACD. J Invest Dermatol 2003;120:641-647.
8. Smith Pease CK, Basketter DA, Patlewicz GY. Contact allergy: the role of skin chemistry and metabolism. Clin Exp Dermatol 2003;28:177-183.
9. Basketter D, Dooms-Goossens A, Karlberg AT, Lepoittevin JP. The chemistry of contact allergy: why is a molecule allergenic? Contact Dermatitis 1995;32:65-73.
10. Lepoittevin JP. Metabolism versus chemical transformation or pro-versus prehaptens? Contact Dermatitis 2006;54:73-4.
11. Vocanson M, Hennino A, Cluzel-Tailhardat M, Saint-Mezard P, Benetiere J, Chavagnac C, et al. CD8+ cells are effector cells of contact dermatitis to common skin allergens in mice. J Invest Dermatol 2006;126:815-820.
12. Zaba LC, Krueger JG, Lowes MA. Resident and "inflammatory" dendritic cells in human skin. J Invest Dermatol 2009;129:302-308.
13. Ryan CA, Gerberick GF, Gildea LA, Hulette BC, Betts CJ, Cumberbatch M, et al. Interactions of contact allergens with dendritic cells: opportunities and challenges for the development of novel approaches to hazard assessment. Toxicol Sci 2005;88:4-11.
14. Sasaky Y, Aiba S. Dendritic cells and contact dermatitis. Clin Rev Allergy Immunol 2007;33:27-34.
15. Allan RS, Waithman J, Bedoui S, Jones CM, Villadangos JA, Zhan Y, et al. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 2006;25:153-162.
16. Arrighi JF, Rebsamen M, Rousset F, Kindler V, Hauser C. A critical role for p38 mitogen-activated protein kinase in the maturation of humanblood derived dendritic cells induced by lipopolysaccharide, TNF-alpha and contact sensitizers. J Immunol 2001;166:3837-3845.
17. Grabbe S, Steinbrink K, Steinert M, Luger TA, Schwarz T. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity. J Immunol 1995;155:4207-4217.
18. Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 1997;388:782-787.
19. Jonuleit H, Kühn U, Müller G, Steinbrink K, Paragnik L, Schmitt E, et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 1997;27:3135-3142.
20. Aiba S, Terunuma A, Manome H, Tagami H. Dendritic cells respond differently to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules. Eur J Immunol 1997;27:3031-308.
21. Megherbi R, Kiorpelidou E, Foster B, Rowe C, Naisbitt DJ, Goldring CE, Park BK. Role of protein haptenation in triggering maturation events in the dendritic cell surrogate cell line THP-1. Toxicol Appl Pharmacol 2009;238:120-132.
22. Mizuashi M, Ohtani T, Nakagawa S, Aiba S. Redox imbalance induced by contact sensitizers triggers the maturation of dendritic cells. J Invest Dermatol 2005;124:579-586.
23. Martin SF, Dudda JC, Bachtanian E, Lembo A, Liller S, Dürr C. Toll-like receptor and IL-12 signaling control susceptibility to contact dermatitis. J Exp Med;205:2151-2162.
24. Schwarzenberger K, Udey MC. Contact allergens and epidermal pro-inflammatory cytokines modulate Langerhans cell E-cadherin expression in situ. J Invest Dermatol 1996;106:553-558.
25. Aiba S, Nakagawa S, Ozawa H, Miyake K, Yagita H, Tagami H. Up-regulation of alfa 4 integrin on activated Langerhans cells: analysis of adhesion molecules on Langerhans cells relating to their migration from skin to draining lymph node. J Invest Dermatol 1993;100:143-147.
26. Jakob T, Udey MC. Regulation of E-cadherinmediated adhesion in Langerhans cell-like dendritic cells by inflammatory mediators that mobilize Langerhans cells in vivo. J Immunol 1998;160:4067-4073.
27. Nakae S, Naruse-Nakajima C, Sudo K, Horai R, Asano M, Iwakura Y. IL-1α, but not IL-1β is required for contact allergen-specific T cell activation during the sensitization phase in contact hypersensitivity. Int Immunol 2001;13:1471-1478.
28. Nakae S, Asano M, Horai R, Sakaguchi N, Iwakura Y. IL-1 enhances T-cell dependent antibody production through induction of CD40 ligand and OX40 on T cells. J Immunol 2001;167:90-97.
29. Freudenberg MA, Esser PR, Jakob T, Galanos C, Martin SF. Innate and adaptive immune responses in contact dermatitis: analogy with infections. G Ital Dermatol Venereol 2009;144:173-185.
30. He D, Wu L, Kim HK, Li H, Elmets CA, Xu H. IL-17- producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses. J Immunol 2006 15;177:6852-6858.
31. Jin H, Kumar L, Mathias C, Zurakowski D, Oettgen H, Gorelik L, et al. Toll-like receptor is important for T(H)1 response to cutaneous sensitization. J Allergy Clin Immunol 2009;123:875-882.
32. Askenase PW, Itakura A, Leite-de-Moraes MC, Lisbonne M, Roongapinun S, Goldstein DR, et al. TLR-dependent IL-4 production by invariant Valpha14+Jalpha18+ NKT cells to initiate contact sensitivity in vivo. J Immunol 2005;175:6390-6401.
33. Yusuf N, Nasti TH, Huang CM, Huber BS, Jaleel T, Lin HY, et al. Heat shock proteins HSP27 and HSP70 are present in the skin and are important mediators of allergic contact hypersensitivity. J Immunol 2009;182:675-683.
34. Saint-Mezard P, Berard F, Dubois B, Kaiserlian D, Nicolas JF. The role of CD4+ and CD8+ T cells in contact hypersensitivity and allergic contact dermatitis. Eur J Dermatol 2004;14:131-138.
35. Xu H, DiIulio NA, Fairchild RL. T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells. J Exp Med 1996;183:1001-1012.
36. Xu H, Heeger PS, Fairchild RL. Distinct roles for B7-1 and B7-2 determinants during priming of effector CD8+ Tc1 and regulatory CD4+ Th2 cells for contact hypersensitivity. J Immunol 1997;159: 4217-4226.
37. Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol 2005;23:515-548.
38. Kim HK, Guan H, Zu G, Li H, Wu L, Feng X. Highlevel expression of B7-H1 molecules by dendritic cells suppresses the function of activated T cells and desensitizes allergen-primed animals. J Leukoc Biol 2006;79:686-695.
39. Burns R, Luzina I, Nasir A, Haidaris CG, Barth RK, Gaspari AA. Keratinocyte-derived, CD80-mediated costimulation is associated with haptenspecific IgE production during contact hypersensitivity to TH1 haptens. J Allergy Clin Immunol 2005;115:383-390.
40. Gorbachev AV, Heeger PS, Fairchild RL. CD4+ and CD8+ T cell priming for contact hypersensitivity occurs independently of CD40-CD154 interactions. J Immunol 2001;166:2323-2332.
41. Chen AI, McAdam AJ, Buhlmann JE, Scott S, Lupher ML Jr, Greenfield EA, et al. OX40-ligand has a critical costimulatory role in dendritic cell: T cell interactions. Immunity 1999;11:689-698.
42. Grewal IS, Flavell RA. The role of CD40 ligand in costimulation and T-cell activation. Immunol Rev 1996;153:85-106.
43. Schönbeck U, Libby P. The CD40/CD154 receptor/ ligand dyad. Cell Mol Life Sci 2001;58:4-43.
44. Xu Y, Song G. The role of CD40/CD154 interaction in cell immunoregulation. J Biomed Sci 2004;11:426-438.
45. Quezada SA, Jarvinen LZ, Lind EF, Noelle RJ. CD40/CD154 interactions at the interface of tolerance and immunity. Annu Rev Immunol 2004;22:307-328.
46. Miga AJ, Masters SR, Durell BG, Gonzalez M, Jenkins MK, Maliszewski C, et al. Dendritic cell longevity and T cell persistence is controlled by CD154-CD40 interactions. Eur J Immunol 2001;31:959-965.
47. Gorbachev AV, DiIulio NA, Fairchild RL. IL-12 augments CD8+ cell development for contact sensitivity responses and circumvents anti- CD154 antibody-mediated inhibition. J Immunol 2001;167:156-162.
48. Li L, Sad S, Kägi D, Mosmann TR. CD8Tc1 and Tc2 cells secrete distinct cytokine patterns in vitro and in vivo but induce similar inflammatory reactions. J Immunol 1997;158:4152-4161.
49. Sabatté J, Maggini J, Nahmod K, Amaral MM, Martínez D, Salamone G. Interplay of pathogens, cytokines and other stress signals in the regulation of dendritic cell function. Cytokine Growth Factor Rev 2007;18:5-17.
50. Martin S, Delattre V, Leicht C, Weltzien HU, Simon JC. A high frequency of allergen-specific CD8+ Tc1 cells is associated with the murine immune response to the contact sensitizer trinitrophenyl. Exp Dermatol 2003;12:78-85.
51. Ebert LM, Schaerli P, Moser B. Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues. Mol Immunol 2005;42:799-809.
52. Sallusto F, Lenig D, Förster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999;401:708-712.
53. Walzer T, Marçais A, Saltel F, Bella C, Jurdic P, Marvel J. Cutting edge: immediate RANTES secretion by restricting memory CD8 T cells following antigenic stimulation. J Immunol 2003;170:1615-1659.
54. Santamaria-Babí LF. CLA(+) T cells in cutaneous diseases. Eur J Dermatol 2004;14:13-18.
55. Smithson G, Rogers CE, Smith PL, Scheidegger EP, Petryniak B, Myers JT, et al. Fuc-TVII is required for T-helper and T-cytotoxic 1 lymphocyte selectin ligand expression and recruitment in inflammation, and together with Fuc-TIV regulates naïve T cell trafficking to lymph nodes. J Exp Med 2001;194:601-614.
56. Cavani A, Nasorri F, Prezzi C, Sebastiani S, Albanesi C, Girolomoni G. Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. J Invest Dermatol 2000;114:295-302.
57. Akiba H, Kehren J, Ducluzeau MT, Krasteva M, Horand F, Kaiserlian D, et al. Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD8+ cytotoxic 1 cells inducing keratinocyte apoptosis. J Immunol 2002;168:3079-3087.
58. Gorbachev AV, Fairchild RL. CD4+ cells regulate CD8+ cell-mediated cutaneous immune responses by restricting effector T cell development through a Fas ligand-dependent mechanism. J Immunol 2004;172:2286-2295.
59. Gorbachev AV, Fairchild RL. Regulatory role of CD4+ T cells during the development of contact hypersensitivity responses. Immunol Res 2001;24:69-77.
60. Tsuji RF, Kawikova I, Ramabhadran R, Akahira-Azuma M, Taub D, Hugli TE. Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment. J Immunol 2000;165:1588-1598.
61. Borges E, Tietz W, Steegmaier M, Moll T, Hallmann R, Hamann A, et al. P-selectin glycoprotein ligand-1 (PSGL-1) on T helper 1 but not on T helper 2 cells binds to P-selectin and supports migration into inflamed skin. J Exp Med 1997;185:573-578.
62. Xie H, Lim YC, Luscinskas FW, Lichtman AH. Acquisition of selectin binding and peripheral homing properties by CD4+ and CD8+ cells. J Exp Med 1999;189:1765-1776.
63. Goebeler M, Trautmann A, Voss A, Bröcker EV, Toksoy A, Gillitzer R. Differential and sequential expression of multiple chemokines during elicitation of allergic contact hypersensitivity. Am J Pathol 2001;158:431-440.
64. Askenase PW. Yes T cells, but three different T cells (alphabeta, gammadelta and NK T cells), and also B-1 cells mediate contact sensitivity. Clin Exp Immunol 2001;125:345-350.
65. Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ, Baxter AG. NKT cells: facts, functions and fallacies. Immunol Today 2000;21:573-583.
66. Campos RA, Szczepanik M, Lisbonne M, Itakura A, Leite-de-Moraes M, Askenase PW. Invariant NKT cells rapidly activated via immunization with diverse contact antigens collaborate in vitro with B1-cells to initiate contact sensitivity. J Immunol 2006;177:3686-3694.
67. Campos RA, Szczepanik M, Itakura A, Akahira-Azuma M, Sidobre S, Kronenberg M, et al. Cutaneous immunization rapidly activates liver invariant Valpha14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity. J Exp Med 2003;198:1785-1796.
68. Campos RA, Szczepanik M, Itakura A, Lisbonne M, Dey N, Leite-de-Moraes MC, et al. Interleukin- 4-dependent innate collaboration between iNKT cells and B-1 B cells controls adaptive contact sensitivity. Immunology 2006;117:536-547.
69. Askenase PW, Tsuji RF. B1 B cell IgM antibody initiates T cell elicitation of contact sensitivity. Curr Top Microbiol Immunol 2000;252:171-177.
70. Szczepanik M, Akahira-Azuma M, Bryniarski K, Tsuji RF, Kawikova I, Ptak W, et al. B-1 B cells mediate required early T cell recruitment to elicit protein-induced delayed-type hypersensitivity. J Immunol 2003;171:6225-6235.
71. Tsuji RF, Geba GP, Wang Y, Kawamoto K, Matis LA, Askenase PW. Required early complement activation in contact sensitivity with generation of local C5-dependent chemotactic activity, and late T cell IFN-γ: a possible role of B cells. J Exp Med 1997;186:1015-1026.
72. Tsuji RF, Kikuchi M, Askenase PW. Possible involvement of C5/C5a in the efferent and elicitation phases of contact sensititivity. J Immunol 1996;156:4444-4450.
73. Geba GP, Ptak W, Anderson GM, Paliwal V, Ratzlaff RE, Levin J. Delayed-type hypersensitivity in mast cell deficient mice: dependence on platelets for expression of contact sensitivity. J Immunol 1996;157:557-565.
74. Matsuda H, Ushio H, Geba GP, Askenase PW. Human platelets can initiate T cell-dependent contact sensitivity through local serotonin release mediated by IgE antibodies. J Immunol 1997;158:2891-2897.
75. Kobayashi M, Nunomura S, Gon Y, Endo D, Kishiro S, Fukunaga M. Abrogation of high-affinity IgE receptor-mediated mast cell activation at the effector phase prevents contact hypersensitivity to oxazolone. J Invest Dermatol 2009 Sep 10. [Epub ahead of print]
76. van Loveren H, Meade R, Askenase PW. An early component of delayed-type hypersensitivity mediated by T cells and mast cells. J Exp Med 1983;157:1604-1617.
77. Nakae S, Komiyama Y, Narumi S, Sudo K, Horai R, Tagawa Y, et al. IL-1-induced tumor necrosis factor- α elicits inflammatory cell infiltration in the skin by inducing IFN-γ-inducible protein 10 in the elicitation phase of contact hypersensitivity response. Int Immunol 2003;15:251-260.
78. Grabbe S, Steinert M, Mahnke K, Schwartz A, Luger TA, Schwarz T. Dissection of antigenic and irritative effects of epicutaneously applied haptens in mice: evidence that not the antigenic component but nonspecific proinflammatory effects of haptens determine the concentration- dependent elicitation of allergic contact dermatitis. J Clin Invest 1996;98:1158-1164.
79. McHale JF, Harari OA, Marshall D, Haskard DO. Vascular endothelial cell expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule -1 at the onset of eliciting contact hypersensitivity in mice: evidence for dominant role of TNF- α. J Immunol 1999;162:1648-1655.
80. Grabbe S, Schwarz T. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol Today 1998;19:37-44.
81. Albanesi C, Scarponi C, Sebastiani S, Cavani A, Federici M, Sozzani S, Girolomoni G. A cytokineto- chemokine axis between T lymphocytes and keratinocytes can favor Th 1 cell accumulation in chronic inflammatory skin diseases. J Leukoc Biol 2001;70:617-623.
82. Traidl C, Sebastiani S, Albanesi C, Merk HF, Puddu P, Girolomoni G, et al. Disparate cytotoxic activity of nickel-specific CD8+ and CD4+ T cell subsets against keratinocytes. J Immunol 2000;165:3058-3064.
83. Harari OA, McHale JF, Marshall D, Ahmed S, Brown D, Askenase PW, et al. Endothelial cell E- and P-selectin up-regulation in murine contact sensitivity is prolonged by distinct mechanisms occurring in sequence. J Immunol 1999;163:6860-6866.
84. Santamaria Babi LF, Perez Soler MT, Hauser C, Blaser K. Skin-homing T-cells in human cutaneous allergic inflammation. Immunol Res 1995;14:317-324.
85. Hwang JM, Yamanouchi J, Santamaria P, Kubes P. A critical temporal window for selectin-dependent CD4+ lymphocyte homing and initiation of late-phase inflammation in contact sensitivity. J Exp Med 2004;199:1223-1234.
86. Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD. IFN-γ-inducible protein 10 (IP-10; CXCL-10)-deficient mice revealed a role for IP-10 in effector T cell generation and trafficking. J Immunol 2002;168:3195-3204.
87. Santamaria Babi LF, Moser B, Perez Soler MT, Moser R, Loetscher P, Villiger B. The interleukin- 8 receptor B and CXC chemokines can mediate transendothelial migration of human skin homing T cells. Eur J Immunol 1996;26:2056-2061.
88. Campbell JJ, Haraldsen G, Pan J, Rottman J, Qin S, Ponath P, et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 1999;400:776-780.
89. Homey B, Dieu-Nosjean MC, Wiesenborn A, Massacrier C, Pin JJ, Oldham E, et al. Up-regulation of macrophage inflammatory protein 3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol 2000;164:6621-6632.
90. Rottman JB, Smith TL, Ganley KG, Kikuchi T, Krueger JG. Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alphaEbeta7 in the pathogenesis of psoriasis. Lab Invest 2001;81:335-347.
91. Homey B, Wang W, Soto H, Buchanan ME, Wiesenborn A, Catron D, et al. Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J Immunol 2000;164:3465-3470.
92. Morales J, Homey B, Vicari AP, Hudak S, Oldham E, Hedrick J, et al. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci U S A 1999;96:14470-14475.
93. Moser B, Loetscher P. Lymphocyte traffic control by chemokines. Nat Immunol 2001;2:123-128.
94. Nakamura K, Williams IR, Kupper TS. Keratinocyte- derived monocyte chemoattractant protein 1 (MCP-1): analysis in a transgenic model demonstrates MCP-1 can recruit dendritic and Langerhans cells to skin. J Invest Dermatol 1995;105:635-6343.
95. Mizumoto N. Analysis of contact hypersensitivity response in human monocyte chemoattractant protein-1 (MCP-1) transgenic mice. Hokkaido Igaku Zasshi 1999;74:199-216.
96. Mizumoto N, Iwabichi K, Nakamura H, Ato M, Shibaki A, Kawashima T, et al. Enhanced contact hypersensitivity in human monocyte chemoattractant protein-1 transgenic mouse. Immunobiology 2001;204:477-493.
97. Paradis TJ, Cole SH, Nelson RT, Gladue RP. Essential role of CCR6 in directing activated T cells to the skin during contact hypersensitivity. J Invest Dermatol 2008;128:628-633.
98. Reiss Y, Proudfoot AE, Power CA, Campbell JJ, Butcher EC. CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T-cell attracting chemokine (CTACK) in lymphocyte. J Exp Med 2001;194:1541-1547.
99. Zhao Y, Balato A, Fishelevich R, Chapoval A, Mann DL, Gaspari AA. Th17/Tc17 infiltration and associated cytokine expression in elicitation phase of allergic contact dermatitis. Br J Dermatol 2009;161: 1301-1306.
100. Yao C, Sakata D, Esaki Y, Li Y, Matsuoka T, Kuroiwa K, et al. Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat Med 2009;15:633-640.
101. Boniface K, Bak-Jensen KS, Li Y, Blumenschein WM, McGeachy MJ, McClanahan TK, et al. Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling. J Exp Med 2009;206:535-548.
102. Khayrullina T, Yen JH, Jing H, Ganea D. In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells. J Immunol 2008;181:721-735.
103. Larsen JM, Bonefeld CM, Poulsen SS, Geisler C, Skov L. IL-23 and T(H)17-mediated inflammation in human allergic contact dermatitis. Allergy Clin Immunol 2009;123:486-492.
104. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th 17 cells. Annu Rev Immunol 2009;27:485-517.
105. Awasthi A, Kuchroo VK. Th17 cells: from precursors to players in inflammation and infection. Int Immunol 2009;21:489-498.
106. Trautmann A, Akdis M, Kleemann D, Altznauer F, Simon HU, Graeve T, et al. T-cell mediated Fasinduced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest 2000;106:25-35.
107. Jonuleit H, Schmitt E. The regulatory T cell family: distinct subsets and their interactions. J Immunol 2003;171:6323-6327.
108. Chan SH, Cosgrove D, Waltzinger C, Benoist C, Mathis D. Another view of the selective model of thymocyte selection. Cell 1993;73:225-236.
109. Desvignes C, Etchart N, Kehren J, Akiba I, Nicolas JF, Kaiserlian D. Oral administration of hapten inhibits in vivo induction of specific cytotoxic CD8+ T cells mediating tissue inflammation: a role for regulatory CD4+ T cells. J Immunol 2000;164:2515-2522.
110. Yanaba K, Bouaziz JD, Matsushita T, Tsubata T, Tedder TF. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol 2009;182:7459-7472.
111. Bouaziz JD, Yanaba K, Tedder TF. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol Rev 2008;224:201-214.
112. Minang JT, Areström I, Zuber B, Jönsson G, Troye-Blomberg M, Ahlborg N. Nickel-induced IL-10 down-regulates Th1- but not Th2-type cytokine responses to the contact allergen nickel. Clin Exp Immunol 2006;143:494-502.
113. Kemper C, Chan AC, Green JM, Brett KA, Murphy KM, Atkinson JP. Activation of human CD4+ cells with CD3 and CD46 induces a T regulatory cell 1 phenotype. Nature 2003;421:388-392.
114. Steinbrink K, Wölfl M, Jonuleit H, Knop J, Enk AH. Induction of tolerance by IL-10-treated dendritic cells. J Immunol 1997;159:4772-4780.
115. Levings MK, Sangregorio R, Galbiati F, Squadrone S, de Waal Malefyt R, Roncarolo MG. IFN-α and IL-10 induce the differentiation of human type I T regulatory cells. J Immunol 2001;166:5530-5539.
116. Jonauleit H, Schmitt E, Schuler G, Knop J, Enk AH. Induction of interleukin 10-producing nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cell. J Exp Med 2000;192:1213-1222.
117. Jonuleit H, Schmitt E, Steinbrink K, Enk AH. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol 2001;22:394-400.
118. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE. A CD4+T cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-742.
119. Yamagiwa S, Gray JD, Hashimoto S, Horwitz DA. A role of TGF-β in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. J Immunol 2001;166:7282-7289.
120. Weiner HL. Induction and mechanism of action of transforming growth factor- β-secreting Th3 regulatory cells. Immunol Rev 2001;182:207-214.
121. Dubois B, Chapat L, Goubier A, Kaiserlian D. CD4+CD25+ T cells as key regulators of immune responses. Eur J Dermatol 2003;13:111-116.
122. Apostolou I, Sarukhan A, Klein L, von Boehmer H. Origin of regulatory T cells with known specificity for antigen. Nat Immunol 2002;3:756-763.
123. Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998;188:287-296.
124. Suri-Payer E, Amar AZ, Thornton AM, Shevach EM. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 1998;160:1212-1218.
125. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003;4:330-336.
126. Fragale A, Gabriele L, Stellacci E, Borghi P, Perrotti E, Ilari R. IFN regulatory factor-1 negatively regulates CD4+ CD25+ regulatory T cell differentiation by repressing Foxp3 expression. J Immunol 2008;181:1673-1682.
127. Cederbom L, Hall H, Ivars F. CD4+CD25+ regulatory T cells down-regulate costimulatory molecules on antigen-presenting cells. Eur J Immunol 2000;30:1538-1543.
128. Nakamura K, Kitani A, Strober W. Cell-contact- dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 2001;194:629-644.
129. McHugh RS, Whitters MJ, Piccirillo CA, Young DA, Shevach EM, Collins M. CD4+CD25+ immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002;16:311-323.
130. Takahashi T, Tagami T, Yamazaki S, Uede T, Shimizu J, Sakaguchi N. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000;192:303-310.
131. Coenen JJ, Koenen HJ, van Rijssen E, Boon L, Joosten I, Hilbrands LB. CTLA-4 engagement and regulatory CD4+CD25+ T cells independently control CD8+-mediated responses under costimulation blockade. J Immunol 2006;176:5240-5246.
132. Bour-Jordan H, Blueston JA. CD28 function: a balance of costimulatory and regulatory signals. J Clin Immunol 2002;22:1-7.
133. Oosterwegel MA, Greenwald RJ, Mandelbrot DA, Lorsbach RB, Sharpe AH. CTLA-4 and T cell activation. Curr Opin Immunol 1999;11:294-300.